"The challenge for the coming decade is to expand on multi-disciplinary and multi-sector collaboration aimed at large-scale production of high-quality human pluripotent stem cells, and also, robust and reliable production of high-quality differentiated cells," said Professor Norio Nakatsuji, Founding Director of Kyoto University, iCeMS. "In order to provide adequate support to accelerate such research, a nation should take an evidence-based approach with an understanding of the global trend from a multitude of perspectives."
"This report gives us a bird's eye view of the international stem cell field, drawing on advanced bibliometric techniques to identify national and international trends - where is stem cell research strongest, where is the sector developing fastest, are the results of individual funding initiatives translating into high impact publications, and so on," said Professor Clare Blackburn, MRC Centre for Regenerative Medicine, University of Edinburgh and the Project Coordinator of EuroStemCell. "It has been extremely interesting to analyse these data, they contain a lot of provocative information. We hope readers will gain a new understanding of the shape of the field that will stimulate future policy discussions."
Nick Fowler, Managing Director of Academic and Government Institutions for Elsevier, said, "The aim of this report was to support development in stem cell science and policy discussion by bringing together comprehensive analytical overview of the fields together with insights from experts. We are proud we have been able to collaborate with EuroStemCell, Kyoto University, iCeMS and the experts who have provided their valuable input."
Note to editorsThe following experts are available for interview concerning this report: Shintaro Sengoku, Associate Professor, Kyoto University, iCeMS, Clare Blackburn, Professor, Tissue Stem Cell Biology, MRC Centre for Regenerative Medicine, University of Edinburgh and Project Coordinator of EuroStemCell, and Anders Karlsson, Vice President, Global Academic Relations, Asia Pacific, Elsevier. Technical terms and abbreviations used in the report:
- Pluripotent stem cells can give rise to all of the cell types that make up the body; embryonic stem cells and induced pluripotent stem cells are considered pluripotent.
- (ES or ESC) Embryonic stem cell
- (hES or hESC) human embryonic stem cell
- (iPS or iPSC) induced pluripotent stem cell
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV